Should I Stay?

Discussion in 'ZS Pharma' started by anonymous, Apr 24, 2017 at 12:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I'm reading that Fx006 could be approved in October? You guys don't seem convinced. What do I not know?
     

  2. anonymous

    anonymous Guest

    Great job Nostradamus. Ocular got rejected again for the second time this week. Flex doesn't stand a chance. You can't mix a $10 steroid and another generic and expect the gov to pay $500. It's a Medicare population with oA. This idea is dead...just like Chiasma. Anyone who goes to 503b drug companies deserves to lose their job since they were too dumb to know better...
     

  3. anonymous

    anonymous Guest

    Any news from leadership?
     
  4. anonymous

    anonymous Guest

    Yes, Eric Loong has been promoted!
     
  5. anonymous

    anonymous Guest

    If it were AZ that had posted the original positions I would have never applied.
    AZ cares nothing about customers just share of voice will increase share of market.

    It's really time to look and look hard.
     
  6. anonymous

    anonymous Guest

     
  7. anonymous

    anonymous Guest

    heard Flexion paying base salary up to $175k w total comp at $250k. Can anyone verify?
     
  8. anonymous

    anonymous Guest

    Where did you hear that? As far as I can research, the comp plan is very hush hush. I'm interviewing for a field sales position, so I'd love to hear any reputable input.
     
  9. anonymous

    anonymous Guest

    Am I the only one who feels this comp plan is beyond absurd? It boils down to the AZ reps. We are either paid or penalized for someone else's actions.
    How is this okay? I have never, ever seen such a horribly designed plan in all my years.
     
  10. anonymous

    anonymous Guest

    Agree. This whole situation is the most ridiculous sequence of events . ZS/AZ is going to lose Many of their extremely talented people they spent so much time finding and hiring to launch ZS-9 when and if it ever launches. These most recent reports are nothing but big Pharma ridiculous metrics that make no sense to anybody including the people that came up with them. I'm not even going to get into the ridiculousness of an nrx eu volume. I could type for an hour regarding how horrible they have the set up to reflect anybody's performance. I used to be in sales analytics in a previous life and I can tell you this is the most absurd analysis I've ever seen in my whole career. we are going to start getting pressure on metrics that don't mean a damn thing and it's all like playing at the casino where you end up on these reports is a pull on the slot machine.all depends on what dates/weeks are pulled and what dates/weeks they're comparing to, etc etc etc ....the metric list goes on and on and on. Did any of you look closely at matrix and look at the peaks and valleys of your week to week data? That should tell you enough. It's an absolute crap shoot where you fall on these reports from report to report. There are so many variables that impact each individual territory that it is completely out of the control of each individual ZS rep and is not a reflection of the ZS reps individual ability to sell. Could be horrible formulary ,could be formulary changes, if you're up or down , could be our many AZ counterparts that may suck or are great, just so many variables that there's no way to evaluate a individual ZS rep calling on primary care,internal medicine and clinical cardiologists in this position that were in. This indeed is the biggest joke I've ever dealt with in my whole career. I was going to try to stay here until we launched and see if I can make this work but this is a strong signal of how things are going to be here for a long time because we're not launching anytime soon so, for me, it's time to go. If you don't leave, get ready for your AZ laptop and your every three week bullshit performance ranking which we have absolutely zero control over.it's a shame because there really are alot of really great people here with extraordinary nephrology experience and important cardiology experience where appropriate to be very successful for a launch of ZS9,unfortunately a lot of them are going to be gone. I have to say ZS Pharma leadership has been great to us and they have done all they can, and nobody can really complain about the ZS approach to this whole situation, the whole thing sucks ,we have no control over it at this point and it's time to go.
     
  11. anonymous

    anonymous Guest

    Could not have said it better myself and totally agree. It is very disappointing as this could have been something great. But we've already seen glimpses of what our future holds (= AZ crap) and it is not pretty. And I really hope they don't try to "hold us accountable" to these made up IC numbers - this is the stuff law suits are made of as it is beyond ridiculous. I have crap, useless docs that have zero impact on this EU Nrx bs. Guys who write 8 Trx in 5 weeks can't do crap for me. And "the Rx is a Rx" is baloney bc my total market is huge.
    It really stinks bc I was really looking forward to this and thought I had found a good gig.
     
  12. anonymous

    anonymous Guest

    I fell in the top of the pack on this recent report, and I know that on the next report I'm going to be at the bottom because the next couple weeks in matrix after 7-21 I have a major dip down. I agree that to give us performance reports on an NRX EU on a every three weeks basis compared to baseline from 6 months ago is absurd. Also it has been our direction to call on clinical cardiologists, primary care and internal medicine doctors, and you're judging us on performance based on nrx eu? Like we can have any impact with who You're giving us to call on to begin with? Brilinta is what? 7 ish years old, and still has an average of less than 5% marketshare, if that? There are many reasons for that horrible market share, let's get real here. Yeah but we're going to make a huge change right? Plavix works great and is cheap with no hurdles and challenges for the prescribers and more importantly the patient. I talked to an AZ rep today, and they told me that I just need to concentrate to get the numbers up on selling on our superiority data and that should outweigh all of the cost difference hurdles and dyspnea and everything else, and to ask prescribers what would they put themselves on or a family member. I started laughing on the phone at the AZ rep and she said "what are you laughing about" and I said what you just told me is what has destroyed big pharmaceutical reps credibility and integrity and it's the reason why we have no access anymore to see doctors. And I said "good talking to you" and hung up. AZ, this is a great way for you to lose people (Zs reps) that are the very people that are going to drive your success for ZS 9, when it gets launched. You better change it or you are going to lose a lot of the people that would/could have huge impact to make the new agent succeed, which you are desperately going to need to succeed. Not to mention having a good quality reps in place for roxadustat ( if that ever gets launched, at the rate of our failures I wouldn't count on it ) . AZ will not get any of these highly specialized nephrology people that are at ZS right now to come back once they leave if that drug ever gets approved. Your going to lose many of us if you don't straighten this out. You can read this and think "disgruntled employee" or whatever you want to call it , Café Pharma baloney etc, but go look in the mirror and hold a piece of paper that shows where your stock price is at currently and how much it has dropped The past couple months and the huge failures as of recent with pipeline agents( mystic). Wake up and start making right decisions.
     
  13. anonymous

    anonymous Guest

    what value has been brought by ZS reps compared to us lowly AZ reps? Would love to see the cost benefit analysis. Pretty sure the "elite" ZS reps wouldn't hold up well, especially given the cost of keeping you. The very fact that ZS is now fully incorporated into AZ means they don't have much faith in that drug launching anytime in the near future, if at all.
     
  14. anonymous

    anonymous Guest


    To the AZ rep that wrote this, what you have to understand is none of the ZS reps signed up for this. We signed up for a small start up biotech company with a great culture with an exciting new agent that is needed and to sell in the specialty market place. You as an AZ rep signed up to sell these me too products with completely unrealistic expectations from a big pharma model. There's a big difference on what you signed up to do and what we signed up to do. Your expectations should be different then our expectations since we signed up to do 2 different jobs. We are doing the complete opposite in every single category to what we signed up to do a year and a half ago. As far as pay goes, you can make all the comments you want but the ZS team ALL came from jobs where they had huge successes and made the money they made because of their successes. That's why the ZS leadership team hired the 120 reps that they hired. It was a very long grueling process and they were very selective and picky. It's not like AZ hired us and are compensating us differently than you guys. ZS Did. So please don't get disgruntled with us as we did not do anything to harm you intentionally or to be compared to you. I have no problem with my AZ counterparts and get along with them actually, and they are great people, but please don't degrade us and tear us up based on circumstances and things that have happened with the FDA approval process that has been out of our control. Do you think we would've taken this job if we knew we were going to be selling a 7 + year-old oral antiplatelet with horrible coverage and dyspnea with a generic that works awesome with no hurdles? Do you think we took this job to Sell a SGLT2 inhibitor in a crowded market? Do you think we signed up to work in the big Pharma bullshit micro manage metric environment? Do you think that we would've taken this job if we knew we would be calling on primary care, internal medicine, and clinical cardiologists? The answer is NO
     
  15. anonymous

    anonymous Guest

    completely agee! We'd didn't sign up for this. AZ actually has an opportunity to get this right, maintain at least part of the culture we signed up for - but, now they are slowly destroying every single part of it with this top down mentality and culture. Really! And, and now delaying offers with no legitimate reason? Thanks Fouzia for your military, no engagement leadership, dictator style. So unmotivated. Time to look....
     
  16. anonymous

    anonymous Guest

     
  17. anonymous

    anonymous Guest

    Tic toc!!
    The crocs are circling.

    It is eerily quiet...and the water dark.
     
  18. anonymous

    anonymous Guest

    Any speculation as to what the Rudd call is about?? Especially right on the tail of Fouzia's...?
     
  19. anonymous

    anonymous Guest

    now we know everything....now what? Who's leaving?
     
  20. anonymous

    anonymous Guest

    Well, this def is not their first rodeo. Get rid of the ZS HO folks all at once- wow. How convenient for them
    TV will be gone and then we have no one- he was our only lifeline and we will now slowly be suffocated by big pharma crap that makes zero business sense.
    Now I get why the car allowance will continue - much more difficult to deal with 100 cars when they decide our services are no longer needed...
    So sad -
     
  21. anonymous

    anonymous Guest

    Well...
    What happened to FLT?
    What is going to happen to her..not going to Wilmington and they said she not running anything on the West Coast?

    And what about all the marketing people?

    If TV gone, who will our RD's report to?